Dr. Chapin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
520 E 70th St
Starr 341
New York, NY 10021Phone+1 646-962-2065
Education & Training
- New York Presbyterian Hospital (Cornell Campus)Fellowship, Hematology and Medical Oncology, 2010 - 2013
- Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 2007 - 2010
- University of Vermont College of MedicineClass of 2007
Certifications & Licensure
- NY State Medical License 2010 - 2022
Clinical Trials
- A Study of AG-348 in Adult Participants With Pyruvate Kinase (PK) Deficiency Start of enrollment: 2015 Jun 26
Publications & Presentations
PubMed
- 431 citationsFibrinolysis and the control of blood coagulation.John Chapin, Katherine A. Hajjar
Blood Reviews. 2015-01-01 - 83 citationsEculizumab in the treatment of refractory idiopathic thrombotic thrombocytopenic purpura.John Chapin, Babette B. Weksler, Cynthia M. Magro, Jeffrey Laurence
British Journal of Haematology. 2012-06-01 - 5 citationsAn update on the US adult thalassaemia population: a report from the CDC thalassaemia treatment centres.John Chapin, Alan R. Cohen, Ellis J. Neufeld, Elliott Vichinsky, Patricia J. Giardina
British Journal of Haematology. 2021-11-14
Press Mentions
- Peri- and Postpartum Management of Patients with Factor XI DeficiencyJanuary 1st, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: